Genscript Biotech Stock (GNNSF)
Track Genscript Biotech stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
GNNSF
Genscript Biotech
healthcare
$1.60
▼ -0.72 (-32.73%) past year
Market Cap
$3.28B
P/E Ratio
—
1Y Return
-32.73%
EPS (TTM)
-$0.25
Read the latest TheStreet Pro articles mentioning Genscript Biotech, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
1 articleDaily Diary Mentions
0 mentionsNo diary mentions for GNNSF yet.
